Fetal and Newborn Health Program
The Fetal and Newborn Health Program is dedicated to understanding the mechanisms of typical and atypical fetal and newborn growth, such as intrauterine growth restriction and pre-eclampsia, to develop non-invasive and safe methods of assessing fetal, newborn and maternal health. This research program is recognized internationally and is highly regarded for its bench-to-bedside translational research.
Relevance of the Program
CHRI is recognized internationally as one of the strongest prenatal research
groups in the world. As part of this group, the Fetal and Newborn Health
Program gains strength from the multidisciplinary research expertise.
The Program is also affiliated with both clinical and basic science departments
with strong academic leadership and a commitment to research. It has received
support from CHRI, Lawson Health Research Institute, St. Joseph’s
Health Care, London Health Sciences Centre and The University of Western
Ontario.
Opportunities Created
Partnerships with Western’s Departments of Obstetrics
and Gynaecology and Paediatrics provide support, funding and research
space. This contributes to recruitment and renewal of scientists and close
interaction between the Program and the Developmental Biology Program.
Moving laboratories to the new Victoria Research Laboratory facilities also increases interaction with other relevant investigative groups within CHRI (Developmental Biology) and the London Regional Cancer Program. Construction of the London Regional Innovarium on the Western campus will allow researchers to increase collaborations with the Robotics Surgery Group based at the University campus of London Health Sciences Centre.
Clinical translational research is an important component of the Program. Research space at the new Grace Donnelly Pavilion and the Children’s Hospital of Western Ontario will facilitate research at this new hospital site.
The Program’s Future Direction
The Program aims to recruit investigators to ensure continued recognition
as a high profile research group internationally. Academic development
and interaction with other relevant investigative groups are also important
objectives.
Leaders and scientists from this program are involved in the functional
planning for the new Women’s and Children’s Hospital. This
will ensure space for clinical research and a perinatal wet laboratory.
Our Team
Chair:
Dr. Kaiping Yang
Scientists:
Dr. Andy Babwah
Dr. Madhulika Gupta
Dr. Victor Han
Dr. Jeffery Nisker
Dr. Timothy Regnault
Dr. Bryan Richardson
Dr. Doris Yuen
Associate Scientists:
Dr. Orlando daSilva
Dr. Barbra de Vrijer
Dr. Valter Feyles
Dr. Rob Gratton
Dr. Rob Hammond
Dr. David Lee
Dr. Michael Lehman
Dr. Michelle Mottola
Dr. Keith St. Lawrence
Dr. Fred Possmayer
